ZTS
Zoetis Inc.
NYSEUSDEQUITY
DELAYED
Last price
77.95
▲ 2.93 (3.91%)
MARKET · —
Price
Open
75.23
Prev close
75.02
Day high
78.59
Day low
75.18
Volume
5.05M
Market cap
—
P/E (TTM)
—
52W range
71.00 – 157.21
Trailing performance
Returnvs SPY
1W
+5.34%
+6.7%
1M
+4.24%
+0.5%
3M
-2.92%
-6.0%
6M
-39.64%
-50.7%
YTD
-38.22%
-50.5%
1Y
-50.41%
-70.4%
3Y
-58.27%
-132.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
74.97
+3.97% from price
SMA 20
75.64
+2.76% from price
SMA 50
75.94
+2.36% from price
SMA 100
87.46
-10.87% from price
SMA 200
105.24
-26.14% from price
EMA 12
75.39
+3.40% from price
EMA 26
75.64
+3.05% from price
EMA 50
78.11
-0.20% from price
RSI (14)
54.8
Neutral
MACD (12,26,9)
-0.26
Hist 0.29
ATR (14)
3.34
4.30% of price
Realised vol 30D
36.3%
Annualised
Bollinger upper
78.90
20, 2σ
Bollinger lower
72.39
20, 2σ
50 / 200 cross
Death
75.94 vs 105.24
Trend bias
Below 200
-26.14%
Risk profile
Beta vs SPY
0.59
Less volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
36.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-54.1%
Peak to trough
Max drawdown 5Y
-70.9%
Peak to trough
ATR 14
3.34
4.30% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
MS Global Franchise Portfolio's Bold Q2 2026 Move: Exits Zoetis Inc, a -2.6% Portfolio Impact
GuruFocus.com · 16h ago
3 of Wall Street’s Favorite Stocks We’re Skeptical Of
StockStory · 21h ago
Stifel Adjusts Price Target on Zoetis to $80 From $85, Maintains Hold Rating
MT Newswires · 2d ago
Zoetis (ZTS) Stock Still Looks Cheap After a 62% Slide
Simply Wall St. · 3d ago
Is Zoetis’ Lowered 2026 Outlook and Simparica Trio EUA Altering The Investment Case For Zoetis (ZTS)?
Simply Wall St. · 3d ago
Should You Continue to Retain PAHC Stock in Your Portfolio?
Zacks · 3d ago
3 High-Yielding Dividend Stocks That Have Doubled Their Payouts in 5 Years
Motley Fool · 3d ago
GE HealthCare names new CFO
MedTech Dive · 3d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.